Items where authors include "Brown, E."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Brown, E., Swinscoe, G., Lefteri, D.A. et al. (14 more authors) (2024) Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection. eLife, 13. e68404. ISSN 2050-084X

Ashford, F. orcid.org/0000-0002-2946-3864, Kuo, C.=W. orcid.org/0000-0002-1903-7618, Dunning, E. orcid.org/0009-0008-3373-9078 et al. (6 more authors) (2024) Cysteine post‐translational modifications regulate protein interactions of caveolin‐3. The FASEB Journal, 38 (5). e23535. ISSN 0892-6638

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Tavabie, O.D., Abbott, J., Abeysekera, K.W.M. et al. (97 more authors) (2024) Regional variations in inpatient decompensated cirrhosis mortality may be associated with access to specialist care: results from a multicentre retrospective study. Frontline Gastroenterology, 15 (1). pp. 3-13. ISSN 2041-4137

Dayimu, A. orcid.org/0000-0001-9998-7463, Gupta, A., Matin, R.N. et al. (25 more authors) (2024) A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM). European Journal of Cancer, 196. 113455. ISSN 0959-8049

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Tavabie, O.D., Abbott, J., Abeysekera, K.W. et al. (97 more authors) (2023) Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis. Journal of Hepatology, 79 (4). e165-e167. ISSN 0168-8278

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Tavabie, O.D., Abeysekera, K.W.M., Brennan, P.N. et al. (291 more authors) (2023) Regional variation in characteristics of patients with decompensated cirrhosis admitted to hospitals in the UK. The Lancet Gastroenterology & Hepatology, 8 (7). pp. 604-606. ISSN 2468-1253

Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836

Leary, J., Czyrnek-Delêtre, M., Alsop, A. et al. (12 more authors) (2020) Finding the niche: A review of market assessment methodologies for rural electrification with small scale wind power. Renewable and Sustainable Energy Reviews, 133. 110240. ISSN 1364-0321

Piranavan, P., Li, Y., Brown, E. et al. (2 more authors) (2019) Immune checkpoint inhibitor-induced hypoparathyroidism associated with calcium-sensing receptor-activating autoantibodies. Journal of Clinical Endocrinology and Metabolism, 104 (2). pp. 550-556. ISSN 0021-972X

Tong, A., Manns, B., Wang, A.Y.M. et al. (202 more authors) (2018) Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney International, 94 (6). pp. 1053-1068. ISSN 0085-2538

Peytrignet, S., Denton, C.P., Lunt, M. et al. (60 more authors) (2018) Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology, 57 (2). pp. 370-381. ISSN 1462-0324

Herrick, A.L., Pan, X., Peytrignet, S. et al. (61 more authors) (2017) Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases. ISSN 0003-4967